Mutational analysis of selected genes in the TGFβ, Wnt, pRB, and p53 pathways in primary uveal melanoma

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 9, 2002, Pages 2845-2851

  Edmunds, Scott C ^a   Kelsell, David P ^a   Hungerford, John L ^a   Cree, Ian A ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PROTEIN P14; PROTEIN P15; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMAD PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CHROMOSOME 9P; CLINICAL ARTICLE; DNA METHYLATION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; UVEA MELANOMA;

CELL CYCLE PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UVEAL NEOPLASMS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0036727852     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Prognostic implications of monosomy 3 in uveal melanoma
2. Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma
3. Treatment of metastatic uveal melanoma: Review and recommendations
4. Modelling uveal melanoma
5. Malignant melanoma: Modern black plague and genetic black box
6. Uveal melanoma: Is solar ultraviolet radiation a risk factor?
7. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region
8. Molecular role(s) for integrins in human melanoma invasion
9. Abnormalities of the transforming growth factor-beta pathway in ocular melanoma
10. Transforming growth factor-beta receptor expression in human cornea
11. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
12. Genes involved in melanoma: An overview of INK4a and other loci
13. Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors
14. Mutations and altered expression of p16INK4 in human cancer
15. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma
16. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes
17. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
18. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
19. Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma
20. A melanoma-associated germline mutation in exon lbeta inactivates p14ARF
21. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma
22. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta
23. DPC4 gene in various tumor types
24. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
25. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
26. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma
27. Germline p16 mutations in familial melanoma
28. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France: The French Familial Melanoma Study Group
29. Selective variegated methylation of the p15 CpG island in acute myeloid leukemia
30. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma
31. Comprehensive allelotype study of hepatocellular carcinoma: Potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors
32. P16 UV mutations in human skin epithelial tumors
33. Denaturing high-performance liquid chromatography: A review
34. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
35. Frequency of Smad gene mutations in human cancers
36. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma
37. Constitutional alterations in p16 in patients with uveal melanoma
38. A cell cycle regulator potentially involved in the genesis of many tumor types
39. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression
40. Promoter hypermethxqation: A common cause of reduced p16(INK4a) expression in uveal melanoma
41. No SMAD4 hypermethylation in colorectal cancer
42. DNA methylation regulates p27kipl expression in rodent pituitary cell lines
43. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines
44. Methylation and mutational analysis of p27(kip1) in prostate carcinoma
45. Cell cycle and melanoma: Two different tumours from the same cell type